KMT2A and leukemia: To evaluate the mechanism of action of the ASH1L inhibitors, we performed gene expression studies with AS-99 and AS-nc in MOLM13 and MV4;11 MLL leukemia cells harboring MLL-AF9 and MLL-AF4 translocations, respectively.